An exciting new company driven by seasoned drug hunters is aiming to transform drug discovery with its AI platform for ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

A new study led by NatureServe reveals that more than 22% of native pollinators in North America are at an elevated risk of ...